Pharmafile Logo
Pharmafocus logo
Advanced Search

BMS licences potential first-in-class cancer biologic

July 7, 2011
Research and Development BMS, Cancer, biologics

Bristol-Myers Squibb has signed a $465 million deal for the rights to a potential first-in-class treatment for cancer. IPH2102 is …

News

Former Sanofi-Pasteur MSD president joins board at Genticel

July 6, 2011
Research and Development appointment, research and development

Genticel has named Dr Didier Hoch, former president of Sanofi-Pasteur MSD, to its supervisory board as conseil de surveillance.Dr Hoch …

Appointment
Sanofi

Sanofi launches Jevtana in UK

July 6, 2011
Sales and Marketing Jevtana, Sanofi, prostate cancer

Sanofi has launched its promising advanced prostate cancer drug Jevtana in the UK following EMA approval in March. Jevtana (cabazitaxel) …

News
GlaxoSmithKline

GSK changes the way its US sales reps are assessed

July 6, 2011
Sales and Marketing GSK, pharma sales force

GlaxoSmithKline has revealed a new way of assessing its US sales representatives’ performance in a bid to make the manufacturer’s …

News
Sanofi

Sanofi to research new types of antibiotics

July 6, 2011
Research and Development Antibiotics, Rib-X Pharmaceuticals, Sanofi, research and development news

Sanofi has signed a research collaboration with Rib-X Pharmaceuticals to investigate new types of antibiotics. The French pharma company has …

News

Contract research news in brief

July 6, 2011
Research and Development CIToxLAB, Jubilant, PupPharma, Quintiles, Toxikon, research and development news

Quintiles helps fund Alzheimer’s drug programme, Toxikon starts building a new facility, plus updates from Jubilant, CIToxLAB and PupPharma. Quintiles …

News
Pfizer

Study claims cardiovascular risk to Pfizer’s Champix

July 6, 2011
Research and Development, Sales and Marketing Champix, Chantix, Pfizer, smoking cessation

Pfizer has been drawn into a war of words over its smoking cessation drug Champix after a review of existing …

News
Bayer UK Levitra tweet

Digital Pharma: Bayer tweets breach ABPI Code of Practice

July 5, 2011
Medical Communications Bayer, Code of Practice, Digital Pharma blog, PMCPA, Twitter, medical communications news, social media

Bayer’s use of Twitter has caused the first social media breach of the ABPI Code of Practice. Code regulator the …

News
Merck & Co

Merck to close one facility, boosts another

July 5, 2011
Manufacturing and Production, Research and Development Ireland, Merck & Co, pharma job cuts, pharma manufacturing news

Merck & Co continues to shake up its network of facilities, deciding to close a recently-acquired site in the USA …

News
Novartis Afinitor (everolimus)

Afinitor stops tumour growth in advanced breast cancer

July 5, 2011
Manufacturing and Production, Research and Development Afinitor, Novartis, Votubia, advanced breast cancer

Novartis’ Afinitor has impressed in a late-stage trial by increasing survival in women with advanced breast cancer. The phase III …

News

SCM Pharma appoints Adam Sims

July 5, 2011
Manufacturing and Production, Research and Development appointment, manufacturing and production, research and development

Sterile filling specialist SCM Pharma has bolstered its senior management team with the appointment of Adams Sims as a non-executive …

Appointment

Pfizer re-acquires Rouses Point from Akrimax

July 5, 2011
Manufacturing and Production Pfizer, pharma manufacturing news

Pfizer has decided to buy back a manufacturing facility in Rouses Point, New York, from current owner Akrimax Pharmaceuticals, and …

News

US team make human ‘biocollagen’ in plants

July 5, 2011
Manufacturing and Production collegen, cosmetic surgery, manufacturing and production news, pharma manufacturing news

A team of researchers in the USA have successfully synthesised human collagen in transgenic maize seeds, offering a potential alternative …

News

EMA publishes details of new pharmacovigilance format

July 4, 2011
Research and Development, Sales and Marketing EMA, pharmacovigilance

Pharma companies have been given the highly-specific electronic formats in which they will soon have to submit information on medicines …

News

A bigger conversation: taking market research online

July 4, 2011
Medical Communications, Sales and Marketing digital, market research

The debate around pharma’s use of digital media has tended to focus on building relationships with patients or healthcare professionals …

Feature

Xarelto receives FDA approval

July 4, 2011
Sales and Marketing Bayer, Eliquis, Johnson & Johnson, Pradaxa, Xarelto, anticoagulant

Bayer and Johnson & Johnson’s oral blood thinner Xarelto has been approved in the US for the prevention of deep …

News

Nycomed gains new European licence for cancer pain spray

July 4, 2011
Sales and Marketing Nycomed, cancer pain, pain therapeutics

The European Commission has approved Nycomed’s Instanyl in a single-dose nasal spray for the treatment of breakthrough pain in cancer …

News
reckitt_benckiser_camillo_pane

Reckitt Benckiser promotes Camillo Pane

July 4, 2011
Sales and Marketing appointment, sales and marketing

Reckitt Benckiser’s UK general manager Camillo Pane has been promoted to senior vice president – global category officer healthcare. Reporting …

Appointment

Digital Pharma: The Best of Health in digital

July 1, 2011
Medical Communications Best of Health, Digital Pharma blog, awards, digital marketing, medical communications news

Recognition for digital pharma marketing has been slowly increasing over the last couple of years and last night’s Best of …

News
Eli Lilly & Company

Lilly prepares late-stage pipeline boost

July 1, 2011
Research and Development, Sales and Marketing autoimmune diseases, diabetes, lilly, neuroscience, oncology

Eli Lilly has highlighted diabetes, oncology, autoimmune diseases and neuroscience as key therapy areas within its growth strategy. Within these …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026